A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
An Open-Label Study On The Effects Of Human Secretin For Injection (CHIROSTIM) On Pancreatic Fluid Composition In Normal Human Volunteer Participants
Sponsor: ChiRhoClin, Inc.
This observational or N/A phase trial investigates Chronic Pancreatitis and Exocrine Pancreatic Insufficiency and is currently actively recruiting participants. ChiRhoClin, Inc. leads this study, which shows 3 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
3 versions recorded-
May 4, 2026 — Present [daily]
Recruiting
Status: Not Yet Recruiting → Recruiting · Phase: PHASE4 → None
-
Feb 2026 — May 2026 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2026 — Feb 2026 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Contact Information
- ChiRhoClin, Inc.
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .